We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 8 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 40 actions collected · 15 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 11. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 05. 08. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 04. 03. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2026. 03. 28. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 03. 27. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 03. 04. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2026. 01. 15. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2026. 01. 14. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2026. 01. 09. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 12. 13. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 11. 08. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2025. 11. 08. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 10. 09. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 08. 14. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 06. 10. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 05. 17. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2025. 05. 17. | Keefe, Bruyette & Woods | — | Maintain | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2025. 04. 07. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 04. 04. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2025. 03. 08. | Goldman Sachs | — | Maintain | Buy → Buy | — | Goldman Sachs: Buy |
| 2025. 03. 07. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 01. 13. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2025. 01. 07. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2024. 12. 20. | Keefe, Bruyette & Woods | — | Maintain | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2024. 12. 09. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 11. 21. | HSBC | — | Initiate coverage | — → Buy | — | HSBC: Buy |
| 2024. 11. 09. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 11. 09. | Keefe, Bruyette & Woods | — | Maintain | Outperform → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2024. 11. 08. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2024. 10. 08. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 08. 15. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2024. 08. 15. | Barclays | — | Maintain | Overweight → Overweight | — | Barclays: Overweight |
| 2024. 08. 14. | Piper Sandler | — | Maintain | Overweight → Overweight | — | Piper Sandler: Overweight |
| 2024. 05. 21. | UBS | — | Initiate coverage | — → Buy | — | UBS: Buy |
| 2024. 05. 21. | Citigroup | — | Initiate coverage | — → Buy | — | Citigroup: Buy |
| 2024. 05. 20. | Barclays | — | Initiate coverage | — → Overweight | — | Barclays: Overweight |
| 2024. 05. 20. | Jefferies | — | Initiate coverage | — → Buy | — | Jefferies: Buy |
| 2024. 05. 20. | Keefe, Bruyette & Woods | — | Initiate coverage | — → Outperform | — | Keefe, Bruyette & Woods: Outperform |
| 2024. 05. 20. | Piper Sandler | — | Initiate coverage | — → Overweight | — | Piper Sandler: Overweight |
| 2024. 05. 20. | Goldman Sachs | — | Initiate coverage | — → Buy | — | Goldman Sachs: Buy |